Penn Medicine to construct $1.5 billion hospital pavilion

By Admin
US medical giant Penn Medicine has announced plans to build a $1.5 billion Hospital Pavilion in Philadelphia, described as the “largest capital pr...

US medical giant Penn Medicine has announced plans to build a $1.5 billion Hospital Pavilion in Philadelphia, described as the “largest capital project” in its history.

The state-of-the-art facility will be built as an adjunct to Jordan Medical Education Center and is expected to be completed by 2021. It will house a new emergency department, inpatient care for heart and vascular medicine and surgery, neurology and neurosurgery as well as patients from the Abramson Cancer Center.

It is the latest in a string of expansions by the world-renowned academic center, after their acquisition of three hospitals in 2014, worth a total of $1 billion, and the recent partnership with the Princeton HealthCare System which was announced back in March.

Penn Medicine’s Senior VP for Public Affairs Susan Phillips insists the facility, which they are describing as Philadelphia's “most ambitious health care building project”, is being constructed with the future in mind.

She said: “Each of the hospital’s 500 private patient rooms will be designed in a way that will enable them to be converted to different kinds of units as patient care needs change.

“For instance, more intensive care units, if needed – and hybrid operating rooms/intervention suites that will allow physicians to deliver care using new surgical techniques or imaging technologies that will be developed in the coming decades.

“Penn Medicine’s hospitals are an important cornerstone of our far-reaching benefits to people living in the Philadelphia region and beyond.

“The Pavilion will further cement our reputation as a driver of innovation in clinical care and the biomedical sciences.”


Featured Articles

Digital healthcare platform Balanced supports healthy ageing

10,000 people turn 65 in the USA each day. Digital healthcare platform Balanced wants to help them better manage healthy ageing, says CEO Katie Reed

TrueBinding’s antibody drugs fight Alzheimer’s Disease

Dongxu Sun, CEO at TrueBinding, shares how its research & antibody drug development is fighting illnesses such as Alzheimer’s Disease, stroke & more

Cardinal Health’s clinically integrated pharma supply chain

Peter J. Siavelis, SVP & General Manager, Health System & Provider Distribution & Services at Cardinal Health, discusses the integrated pharma supply chain

Healthcare Digital news roundup: digital healthcare & AI

Digital Healthcare

Hospitals must embrace IoMT device security


Mental health support for working women and mothers

Digital Healthcare